Aptevo Therapeutics Inc. Insider Trading for March 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aptevo Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Aptevo Therapeutics Inc. for March 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Option Exercise | M | 0.00 | 14,506 | 0 | 84,235 | |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Option Exercise | M | 0.00 | 9,727 | 0 | 98,741 | |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Option Exercise | M | 0.00 | 9,140 | 0 | 108,468 | |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Payment of Exercise | F | 1.78 | 3,837 | 6,830 | 40,416 | 44.3 K to 40.4 K (-8.67 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Buy | M | 0.00 | 14,506 | 0 | 44,253 | 29.7 K to 44.3 K (+48.76 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Payment of Exercise | F | 1.80 | 2,573 | 4,631 | 29,747 | 32.3 K to 29.7 K (-7.96 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Buy | M | 0.00 | 9,727 | 0 | 32,320 | 22.6 K to 32.3 K (+43.05 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Payment of Exercise | F | 2.02 | 2,148 | 4,339 | 22,593 | 24.7 K to 22.6 K (-8.68 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Gross Jane A | See Remarks | Buy | M | 0.00 | 9,140 | 0 | 25,011 | 15.9 K to 25 K (+57.59 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Option Exercise | M | 0.00 | 18,863 | 0 | 46,725 | |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Option Exercise | M | 0.00 | 6,746 | 0 | 65,588 | |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Option Exercise | M | 0.00 | 7,320 | 0 | 72,334 | |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Payment of Exercise | F | 1.78 | 4,990 | 8,882 | 41,284 | 46.3 K to 41.3 K (-10.78 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Buy | M | 0.00 | 18,863 | 0 | 46,274 | 27.4 K to 46.3 K (+68.82 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Payment of Exercise | F | 1.78 | 1,785 | 3,177 | 27,411 | 29.2 K to 27.4 K (-6.11 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Buy | M | 0.00 | 6,746 | 0 | 29,196 | 22.5 K to 29.2 K (+30.05 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Payment of Exercise | F | 2.02 | 1,936 | 3,911 | 22,450 | 24.4 K to 22.5 K (-7.94 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP, CFO and Treasu ... | Buy | M | 0.00 | 7,320 | 0 | 24,386 | 17.1 K to 24.4 K (+42.89 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Option Exercise | M | 0.00 | 24,836 | 0 | 151,934 | |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Option Exercise | M | 0.00 | 13,902 | 0 | 176,770 | |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Option Exercise | M | 0.00 | 16,269 | 0 | 190,672 | |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Payment of Exercise | F | 1.78 | 6,570 | 11,695 | 69,072 | 75.6 K to 69.1 K (-8.69 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Buy | M | 0.00 | 24,836 | 0 | 75,642 | 50.8 K to 75.6 K (+48.88 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Payment of Exercise | F | 1.80 | 3,678 | 6,620 | 50,806 | 54.5 K to 50.8 K (-6.75 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Buy | M | 0.00 | 13,902 | 0 | 54,484 | 40.6 K to 54.5 K (+34.26 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Payment of Exercise | F | 2.02 | 5,312 | 10,730 | 40,582 | 45.9 K to 40.6 K (-11.57 %) |
| Mar 13 2017 | APVO | Aptevo Therapeutic ... | Stromatt Scott C | Chief Medical Offic ... | Buy | M | 0.00 | 16,269 | 0 | 45,894 | 29.6 K to 45.9 K (+54.92 %) |